EIN 88-0517430

CLL Global Research Foundation

IRS 501(c) type
501(c)(3)
Num. employees
0
State
Year formed
2003
Most recent tax filings
2022-12-01
NTEE code, primary
Description
The CLL Global Research Foundation aims to accelerate progress towards controlling and curing chronic lymphocytic leukemia (CLL) by abolishing it as a threat to patients' lives and health through research. The foundation is part of the US/European Alliance for the Therapy of CLL, which comprises 25 experts in CLL research divided into working groups. Education is also an important aspect of the foundation's work, hosting annual interactive patient education events where doctors discuss emerging therapies, current treatment options, and support resources. In 2022, the event was held virtually.
Total revenues
$1,719,451
2022
Total expenses
$2,136,724
2022
Total assets
$10,938,772
2022
Num. employees
0
2022

Program areas at CLL Global Research Foundation

RESEARCH GRANTS: The CLL Global Research Foundation's primary activity is to accelerate research. The need is urgent to accelerate promising, untapped areas of research. CLL Global provides grants through several mechanisms to fund novel, patient-oriented concepts. The intention is to fund the best CLL science in the world. In particular, CLL Global targets monoclonal antibodies, prognostic factors, vaccines & gene therapy, CLL survival pathway, genetics, molecular targets, and drug development. Continued on Schedule O A Scientific Advisory Board (SAB) develops the research priorities and oversees the development and implementation of the submission, evaluation and funding process for grant application cycles. SAB members have extensive experience in treating CLL patients, developing new drugs and other tools, and studying various aspects of the disease. The research grant section also allows support of postdoctoral fellows conducting a CLL-specific project. In 2022, CLL Global awarded new research/individual grants ranging from $100,000-$250,000. Applicants initially submit proposals for up to $110,000 in funding for one year. Applicants identify project milestones. Upon demonstration of sufficient progress, investigators will be considered for a second year of funding. For accounting purposes, CLL Global expenses grants at the time of completion of a sponsored research agreement.
EDUCATION: CLL Global Research Foundation hosts annual interactive patient education events where CLL patients learn about emerging therapies, current treatment options and support resources from leading CLL experts. In 2022, the event was held virtually again due to the COVID-19 pandemic.
ALLIANCE: The US/European Alliance for the Therapy of CLL (Alliance) is comprised of 25 individuals from the United States and Europe, representing the world's experts in CLL research. The members are divided into working groups focusing on one of five big ideas in CLL research (new drugs, gene/vaccine therapy, genetics, CLL-stromal interactions, transplant/immune reconstitution). The Alliance was built to encourage close collaboration within and among working groups. As such, meetings are held to bring investigators together to collaborate.

Grants made by CLL Global Research Foundation

GranteeGrant descriptionAmount
Dana-Farber Cancer InstituteCLL Research Grant, Alliance$200,000

Who funds CLL Global Research Foundation

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Wolf Creek Charitable FoundationUnrestricted$1,500,000
The Silver Lining FoundationMD Anderson Donation$250,000
Madison Charitable FoundationProgram Funding$50,000
...and 14 more grants received

Personnel at CLL Global Research Foundation

NameTitleCompensation
William WierdaPresident and Chief Executive Officer$14,531
Sam Margaret PaceChief Financial Officer$123,957
Michael KeatingBoard Member$0

Financials for CLL Global Research Foundation

RevenuesFYE 12/2022
Total grants, contributions, etc.$2,693,348
Program services$0
Investment income and dividends$131,862
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$-1,105,759
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$1,719,451

Form 990s for CLL Global Research Foundation

Fiscal year endingDate received by IRSFormPDF link
2022-122023-05-14990View PDF
2021-122022-05-06990View PDF
2020-122021-05-24990View PDF
2019-122020-10-24990View PDF
2018-122019-11-15990View PDF
...and 9 more Form 990s
Data update history
December 24, 2023
Received grants
Identified 10 new grant, including a grant for $1,500,000 from Wolf Creek Charitable Foundation
November 25, 2023
Posted financials
Added Form 990 for fiscal year 2021
July 21, 2023
Posted financials
Added Form 990 for fiscal year 2022
May 6, 2023
Received grants
Identified 1 new grant, including a grant for $5,000 from Alpenglow Foundation
October 2, 2021
Received grants
Identified 3 new grant, including a grant for $1,000,000 from Baldwin Management
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Issues
HealthDiseases and disorders
Characteristics
Provides grantsConducts researchOperates internationallyTax deductible donationsNo full-time employees
General information
Address
1515 Holcombe Blvd Unit 428
Houston, TX 77030
Metro area
Houston-The Woodlands-Sugar Land, TX
County
Harris County, TX
Website URL
cllglobal.org/ 
Phone
(713) 745-2376
IRS details
EIN
88-0517430
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2003
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H30: Cancer Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
Free account sign-up

Want updates when CLL Global Research Foundation has new information, or want to find more organizations like CLL Global Research Foundation?

Create free Cause IQ account